EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity

Masonic Cancer Center, University of Minnesota34 enrolled

Overview

This study will formally test the quality improvement intervention of an EMR based tool that informs medical oncologists visiting a patient for the first time of potential risk of chemotherapy toxicity.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Enrollment

Conditions

Oncology Chemotherapeutic Toxicity Metastatic Solid Tumor

Interventions

Chemotherapy toxicity toolOTHER

CARG is an EMR based tool that informs medical oncologists visiting a patient for the first time of potential risk of chemotherapy toxicity. This intervention will make available a simple calculator which includes: Gender, Height and weight, Cancer Subtype, Hemoglobin, How is your hearing (with hearing aid, if needed)?, Number of falls in the past 6 months, Can you take your own medicines, Does your health limit you in walking one block., During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your social activities (like visiting with friends, relatives, etc.)? and Glomerular filtration rate. The CARG chemotoxicity calculator will be built into the patient navigator and its use will be assessed on a monthly basis and used to inform iteration.

Oncology ConsultationOTHER

Oncologists will consult new patient with a new diagnosis of cancer.

Eligibility

Sex: ALLMin age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * New outpatient visits with a medical oncologist following a new diagnosis of cancer and no prior history of chemotherapy treatment. * aged \> 65 will be included. Exclusion Criteria: * Patients who opt out of clinical research will be excluded from analysis, but not the intervention (which will be applied to all patients). Specifically, as sometimes opt-in/opt out status is coded ambiguously in the data we will only analyze results of patients with clear opt in and no history of opt out. * Patients with no EHR data after initial oncologist appointment.

Locations (1)

Masonic Cancer Center, University of Minnesota

Minneapolis, Minnesota, United States

Outcomes

Primary Outcomes

Unplanned hospitalization rate

Measured at the patient level as a binary outcome (yes/no) based on date of initial visit with the oncologist.

Time frame: Within 3 months of the Index Visit with the oncologist

Secondary Outcomes

Healthcare contact days

Measured at the patient level as a continuous outcome (number of days).

Time frame: Within 3 and 6 months of the Index Visit with the oncologist

Chemotherapy use rate

Measured at the patient level as a binary outcome (yes/no) if patient ever received systemic cancer-directed treatment.

Time frame: Within 3 months of the Index Visit with the oncologist

Chemotherapy modification rate

Measured at the patient level as a binary outcome (yes/no) if patient had dose, schedule, or number of chemotherapy changed.

Time frame: Within 3 months of the Index Visit with the oncologist

Palliative Care Referral

Measured at the patient level as a binary outcome (yes/no) based on presence of a scheduled palliative care appointment

Time frame: Within 6 months of the Index Visit with the oncologist

Chemotherapy toxicity tool use rate

Measured at the patient level as a binary outcome (yes/no) based on whether the oncologist used the tool for that patient.

Time frame: Within 3 months of the Index Visit with the oncologist

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.